Eyeworld

EW NEWS & OPINION 14 April 2016 by Tami O'Brien ASCRS•ASOA Copywriter I f you attended the 2015 ASCRS•ASOA Symposium & Congress in San Diego, you may have seen the huge crowd of attendees hoping to win a new Tesla. What started as a way to encourage more interaction between attendees and exhibitors quickly gained momentum and resulted in a very exciting moment. ASCRS Meet "Tesla Jens" and win a 2016 Model S at the ASCRS•ASOA Symposium & Congress continued on page 17 HEALTHCARE PROFESSIONAL INDICATION AND IMPORTANT SAFETY INFORMATION The STAR S4 IR® Excimer Laser and iDESIGN Advanced WaveScan Studio System for wavefront-guided LASIK in patients with myopia. CAUTION: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. ATTENTION: Reference the Operator's Manual for a complete listing of Indications and Important Safety Information. INDICATIONS: The STAR S4 IR® Excimer Laser and iDESIGN Advanced WaveScan Studio System is indicated for wavefrontguided LASIK in patients with myopia as measured by iDESIGN System up to -11.00 D SE, with up to -5.00 D cylinder; with agreement between manifest refraction (adjusted for optical infinity) and iDESIGN System refraction of 1) SE: magnitude of the difference is ˂ 0.625 D, and 2) cylinder: magnitude of the difference is ≤ 0.5 D; with patients 18 years of age and older, and with refractive stability (a change of ≤ 1.0 D in sphere or cylinder for a minimum of 12 months prior to surgery). CONTRAINDICATIONS: Laser refractive surgery is contraindicated in patients with: collagen vascular, autoimmune, or immunodeficiency diseases, pregnant or nursing women, keratoconus, abnormal corneal topography, epithelial basement membrane disease (EBMD) and degenerations of the structure of the cornea, symptoms of significant dry eyes, corneal thickness would cause anticipated treatment would violate the posterior 250 microns (μm) of corneal stroma, advanced glaucoma, and uncontrolled diabetes. If the patients have severely dry eyes, LASIK may increase the dryness; this may or may not go away. Severe eye dryness may delay healing of the flap or interfere with the surface of the eye after surgery; it may result in poor vision after LASIK. WARNINGS AND PRECAUTIONS: LASIK is not recommended in patients who: have a history of Herpes simplex or Herpes zoster keratitis, have severe allergies or tendency rub their eyes often, are taking the medication Isotretinoin (Accutane®), are taking antimetabolites for any medical conditions. The safety and effectiveness of this laser for LASIK correction have NOT been established in patients: with progressive refractive errors; previous corneal or intraocular surgery; or trauma in the ablation zone, who are taking the medication Sumatriptan (Imitrex®), or Amiodarone hydrochloride (Cordarone®), with corneal neovascularization within 1.0 mm of the ablation zone, over the long term (more than 1 year after surgery), for patients who engage in activities that could endanger or damage the LASIK flap, for patients who have a family history of degenerative corneal disease, history of inflammation of the eye, for patients who have a history of crossed eyes (strabismus) or who have undergone strabismus surgery, prior LASIK or Refractive Surgery, with history of any eye diseases or abnormalities such as corneal scars or active disease, and whose BSCVA is worse than 20/20. To reduce the risk of corneal ectasia, the posterior 250 microns (μm) of corneal stroma should not be violated. The treatment of highly myopic eyes necessitates the removal of significant amounts of corneal tissue. The iDESIGN System calculates the estimated residual bed depth using the pachymetry and intended flap thickness entered by the user. Actual flap thicknesses may vary. If the estimated residual stromal bed is ≤ 320 microns, an in-the-bed pachymetric measurement should be performed. ADVERSE EVENTS: Possible adverse events include loss of best spectacle corrected visual acuity (BSCVA), serious Transient Light Sensitivity Syndrome, serious primary open angle glaucoma, miscreated flap, melting of the flap, severe glare, and severe dry eyes. Complications can include corneal edema, epithelial ingrowth, diffuse lamellar keratitis, foreign body sensation, and pain. ©2015 Abbott Medical Optics Inc. iLASIK, iDESIGN, iDESIGN Advanced WaveScan Studio, WaveScan, and STAR S4 IR are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. PP2015OTH0316 member Thomas Carter, MD, took home the 2015 Tesla Model S. People in his hometown of Ponca City, Oklahoma often stop him on the street to ask about his car. "I have really enjoyed the Tesla," Dr. Carter said. He drove the car home from San Diego, stopping in Phoenix to pick up his son, who gladly helped with the driving. "I drive it to work almost every day. I still get a lot of compliments on its looks and performance." History will repeat itself at the 2016 ASCRS•ASOA Symposium & Congress, where one lucky attendee will win a new 2016 Tesla Model S in deep blue metallic during the raffle drawing on Monday, May 9, at 4:45 p.m. The drawing will be held at the Tesla booth in the ASCRS Exhibit Hall, and the winner must be present to claim the prize. There are several ways to get entry forms. Registered meeting attendees may (a) visit participating exhibitors in the Exhibit Hall, (b) buy a $50 raffle ticket from the New Orleans Acade- my of Ophthalmology to benefit the ASCRS Foundation at the Gateway Booth, or (c) complete the ASCRS Clinical Survey while at the meeting. A maximum of 5 entries per person may be submitted for the drawing. There is one ASCRS member who would love to win this year's Tesla drawing and add to his col- lection of the high-performance, all-electric car. To date, he has acquired 10 Teslas: 6 Roadsters and 4 of the Model S type. His name is Jens Kratholm, MD, and he is the sole ophthalmologist in Narvik, Norway, which lies above the Arctic Circle. Nicknamed "Tesla Jens" by his neighbors and a Tesla "super owner" by the carmaker, Dr. Kratholm is not shy about his admiration for the brand. "Tesla is the only car you should buy," said Dr. Kratholm, who owns no other cars. His primary reason is that the Tesla runs solely on electric- ity. He also cited the acceleration— from 0 to 60 mph in as little as 2.8 seconds—and the fact that the Tesla Model S received the highest safety rating of any car ever tested by the National Highway Traffic Safety Administration, overall and in every subcategory. In addition, Consumer Reports had to alter its rating system to account for the highest-ever score of 103 (out of 100) received by the Model S P85D all-wheel-drive sedan. Consumer Reports also noted the Tesla's "stunning energy efficiency." The car gets the equivalent of 87 miles to the gallon. Unlike other all-electric cars, it is possible to drive up to 300 miles on a single charge. "It's super fast," Dr. Kratholm said, adding that the impressive acceleration is helpful when passing other cars on the winding, moun- tain roads of northern Norway. He likes the technology as well. "The mapping is fantastic. It has a 17-inch touch screen display with Google Maps, so all you have to do is enter an address or location, and it will guide you there." If you're wondering how the Tesla performs in cold weather, Dr. Kratholm has plenty of experience in those conditions. "It has very good traction control, and because it has an electric motor, you get ASCRS update ASCRS member Jens Kratholm, MD, is pictured with 2 of his Teslas in Narvik, Norway. Source: Kjetil Janson

• Cover